We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.73B
AUM Growth
+$80.8M
Cap. Flow
-$10.6M
Cap. Flow %
-0.61%
Top 10 Hldgs %
15.19%
Holding
339
New
36
Increased
105
Reduced
136
Closed
26

Sector Composition

Rank Sector Weight
1 Industrials 18.53%
2 Technology 16.09%
3 Healthcare 14.22%
4 Consumer Discretionary 13.13%
5 Financials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QDEL icon
76
QuidelOrtho
QDEL
$838M
$6.41M 0.37%
237,380
+28,958
+14% +$739K
AX icon
77
Axos Financial
AX
$5.68B
$6.4M 0.37%
274,964
+35,356
+15% +$777K
CEVA icon
78
CEVA Inc
CEVA
$1.08B
$6.36M 0.37%
298,455
+35,981
+14% +$705K
ENDP
79
DELISTED
Endo International plc
ENDP
$6.35M 0.37%
70,759
-1,681
-2% -$141K
KERX
80
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$6.25M 0.36%
490,987
+313,110
+176% +$4.03M
PF
81
DELISTED
Pinnacle Foods, Inc.
PF
$6.23M 0.36%
152,742
-3,531
-2% -$131K
ESL
82
DELISTED
Esterline Technologies
ESL
$6.14M 0.36%
53,650
-9,361
-15% -$1.06M
NCLH icon
83
Norwegian Cruise Line
NCLH
$8.84B
$5.82M 0.34%
107,660
-43,341
-29% -$2.07M
NKTR icon
84
Nektar Therapeutics
NKTR
$2.58B
$5.8M 0.34%
35,172
+4,499
+15% +$925K
KYTH
85
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$5.62M 0.33%
112,080
+13,702
+14% +$575K
CLC
86
DELISTED
Clarcor
CLC
$5.55M 0.32%
84,094
+1,842
+2% +$119K
BRLI
87
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$5.53M 0.32%
156,812
+137,850
+727% +$4.66M
BBRG
88
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$5.42M 0.31%
369,051
+55,395
+18% +$760K
BID
89
DELISTED
Sotheby's
BID
$5.32M 0.31%
125,851
+76,969
+157% +$3.28M
JWN
90
DELISTED
Nordstrom
JWN
$5.29M 0.31%
65,822
+937
+1% +$74.2K
HLX icon
91
Helix Energy Solutions
HLX
$1.41B
$5.02M 0.29%
335,328
+593
+0.2% +$10K
TTEK icon
92
Tetra Tech
TTEK
$9.07B
$4.99M 0.29%
1,038,960
+137,630
+15% +$681K
TFX icon
93
Teleflex
TFX
$5.98B
$4.97M 0.29%
41,143
+5,324
+15% +$616K
TER icon
94
Teradyne
TER
$59.3B
$4.9M 0.28%
259,733
+5,109
+2% +$97.9K
CBRE icon
95
CBRE Group
CBRE
$42.9B
$4.75M 0.28%
122,808
-3,143
-2% -$108K
FLIR
96
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$4.72M 0.27%
151,038
+3,020
+2% +$95.2K
ZD icon
97
Ziff Davis
ZD
$1.98B
$4.67M 0.27%
81,800
+10,591
+15% +$590K
IPGP icon
98
IPG Photonics
IPGP
$3.84B
$4.49M 0.26%
48,393
-839
-2% -$72.4K
JNJ icon
99
Johnson & Johnson
JNJ
$625B
$4.47M 0.26%
44,390
-4,000
-8% -$407K
BC icon
100
Brunswick
BC
$5.28B
$4.42M 0.26%
85,883
+1,718
+2% +$91.2K

Similar funds

Rice Hall James & Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Rice Hall James & Associates held 339 positions worth $1.73B, up 4.9% from $1.65B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates's Q1 2015 filing shows 36 new, 105 increased, 136 reduced and 26 closed positions. Its largest new stake was Axon Enterprise: 785,008 shares worth $18.9M. The largest sale was Bruker, an estimated $20.6M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Rice Hall James & Associates's largest Q1 2015 buy was Axon Enterprise: 785,008 shares worth $18.9M.
  • Rice Hall James & Associates added most to Cray, Inc. in Q1 2015, an estimated $9.36M increase.
  • Rice Hall James & Associates's biggest Q1 2015 reduction was Ambarella, cutting an estimated $10.6M.
  • Rice Hall James & Associates fully exited Bruker in Q1 2015, selling an estimated $20.6M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $1.73B portfolio in Q1 2015.
  • Rice Hall James & Associates opened 36 new positions and closed 26 in Q1 2015.
  • Rice Hall James & Associates's portfolio value rose 4.9% quarter-over-quarter to $1.73B.

Based on Rice Hall James & Associates's 13F filing for Q1 2015, filed 23 Apr 2015.